Clinical trial

Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic…

NCT00060333 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00060333
Title Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma
Official title Phase II Trial Evaluating Resection Followed By Adjuvant Radiation Therapy (RT) For Patients With Desmoplastic Melanoma
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Recurrent Melanoma
Intervention type Radiation
Interventions radiation therapy
Enrollment 20
Start date Jul 1, 2003
Primary completion Jun 1, 2011
Completion Apr 1, 2016
First posted May 7, 2003
Last update posted Mar 17, 2017
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies